Assessment of antioxidant activity, thrombogenicity and MTT assay of bioceramic phosphate as a biomaterial

Hydroxyapatite (HAP), a cornerstone of bone and teeth, has ignited interest due to its potential bioactivity and therapeutic implications. This study comprehensively assesses the multifaceted nature of HAP, delving into its antioxidant, thrombogenic, and cytocompatibility properties. HAP was synthesized via the sol-gel method, achieving a Ca/P ratio 1.66, confirmed by energy-dispersive X-ray spectroscopy (EDS). X-ray diffraction (XRD) verified compound formation, while Fourier transform infrared spectroscopy (FTIR) identified functional groups. Field emission electron microscopy revealed the surface morphology of HAP. Its structural characterization delves into HAP’s functional potential. Utilizing the DPPH (2,2-diphenyl-1-picrylhydrazyl) assay, pure HAP’s ability to neutralize free radicals, a symbol of antioxidant activity, was evaluated. Additionally, thrombogenic studies using the whole blood clotting assay explored HAP’s influence on blood clotting, a crucial factor for biocompatibility. The MTT (3-(4, 5-dimethythiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay was employed in the L929 cell line to assess its interaction with living cells further, shedding light on HAP’s cytotoxicity or potential cell viability enhancement.